Alek Safarian
Directeur Général chez Alsa Management Services Ltd
Profil
Alek Safarian is the founder of Novotech (Australia) Pty Ltd, which was founded in 1996.
He held the titles of Chairman and Chief Executive Officer from 2015 to 2017.
Mr. Safarian is also the founder of Vantage Biosciences Ltd.
Currently, he is the Chief Executive Officer of Alsa Management Services Ltd.
He is also the Executive Chairman of Promatix, Inc. and a Director at Epsilogen Ltd., Avance Clinical Pty Ltd., and Axovia Therapeutics Ltd.
where he holds the title of Director since 2023.
Mr. Safarian received his undergraduate degree in 1986 and his MBA in 1995 from the University of Sydney Business School.
Postes actifs de Alek Safarian
| Sociétés | Poste | Début |
|---|---|---|
Epsilogen Ltd.
 Epsilogen Ltd. Pharmaceuticals: MajorHealth Technology Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom. | Directeur/Membre du Conseil | - |
Alsa Management Services Ltd
 Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | Directeur Général | 01/01/2018 |
Promatix, Inc.
 Promatix, Inc. Data Processing ServicesTechnology Services Promatix, Inc. is based in London, UK. The British company takes a data-driven approach by utilizing a confluence of multi-omic datasets and proprietary algorithms. Promatix, Inc. is a company that was founded to accelerate the process of novel target and drug discovery for cancer patients. The company was founded in 2020, and Robert Balfour has been the CEO of the company since 2021. | Président | - |
Axovia Therapeutics Ltd.
 Axovia Therapeutics Ltd. BiotechnologyHealth Technology Axovia Therapeutics Ltd. develops gene therapies for ciliopathies. The company is based in London, UK. and has subsidiaries in the United States. Axovia Therapeutics was founded in 2023. | Directeur/Membre du Conseil | 08/03/2023 |
Avance Clinical Pty Ltd.
 Avance Clinical Pty Ltd. BiotechnologyHealth Technology Avance Clinical Pty Ltd. is a premium full-service CRO that delivers quality clinical trials for international biotechs. Avance Clinical is based in Thebarton, AU, and has subsidiaries in the United States. The Australian company provides fast, agile, and adaptive solution-oriented clinical research services to biotechs in their drug development phases. The CEO of the company is Yvonne Lungershausen. | Directeur/Membre du Conseil | - |
Anciens postes connus de Alek Safarian
| Sociétés | Poste | Fin |
|---|---|---|
Novotech (Australia) Pty Ltd.
 Novotech (Australia) Pty Ltd. BiotechnologyHealth Technology Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia. | Directeur Général | 01/08/2017 |
Vantage Biosciences Ltd.
 Vantage Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Vantage Biosciences Ltd. develops drugs for diabetic eye disease. The British company was founded by Andre Badalyan, Katie Sunnucks, Graeme R. Martin, Alek Safarian. | Fondateur | - |
Formation de Alek Safarian
| University of Sydney Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Novotech (Australia) Pty Ltd.
Novotech (Australia) Pty Ltd. BiotechnologyHealth Technology Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia. | Health Technology |
Epsilogen Ltd.
Epsilogen Ltd. Pharmaceuticals: MajorHealth Technology Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom. | Health Technology |
Alsa Management Services Ltd
Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | Finance |
Avance Clinical Pty Ltd.
Avance Clinical Pty Ltd. BiotechnologyHealth Technology Avance Clinical Pty Ltd. is a premium full-service CRO that delivers quality clinical trials for international biotechs. Avance Clinical is based in Thebarton, AU, and has subsidiaries in the United States. The Australian company provides fast, agile, and adaptive solution-oriented clinical research services to biotechs in their drug development phases. The CEO of the company is Yvonne Lungershausen. | Health Technology |
Promatix, Inc.
Promatix, Inc. Data Processing ServicesTechnology Services Promatix, Inc. is based in London, UK. The British company takes a data-driven approach by utilizing a confluence of multi-omic datasets and proprietary algorithms. Promatix, Inc. is a company that was founded to accelerate the process of novel target and drug discovery for cancer patients. The company was founded in 2020, and Robert Balfour has been the CEO of the company since 2021. | Technology Services |
Vantage Biosciences Ltd.
Vantage Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Vantage Biosciences Ltd. develops drugs for diabetic eye disease. The British company was founded by Andre Badalyan, Katie Sunnucks, Graeme R. Martin, Alek Safarian. | Health Technology |
Axovia Therapeutics Ltd.
Axovia Therapeutics Ltd. BiotechnologyHealth Technology Axovia Therapeutics Ltd. develops gene therapies for ciliopathies. The company is based in London, UK. and has subsidiaries in the United States. Axovia Therapeutics was founded in 2023. | Health Technology |
